肝脏 ›› 2025, Vol. 30 ›› Issue (6): 796-800.

• 肝功能衰竭 • 上一篇    下一篇

新COSSH评分短期动态变化对HBV相关慢加急性肝衰竭患者的预测价值

刘玉盒, 张樱, 李斌华, 谢青, 陈小勇, 闫雪华   

  1. 730030 甘肃 兰州市第二人民医院
  • 收稿日期:2025-01-24 出版日期:2025-06-30 发布日期:2025-08-08
  • 通讯作者: 闫雪华,Email:137552748@qq.com

The clinical predictive value of short-term dynamic changes of new COSSH scores in patients with hepatitis B virus-related acute-on-chronic liver failure

LIU Yu-he, ZHANG Ying, LI Bin-hua, XIE Qing, CHEN Xiao-yong, YAN Xue-hua   

  1. The Second People’s Hospital of Lanzhou City, Gansu 730030, China
  • Received:2025-01-24 Online:2025-06-30 Published:2025-08-08
  • Contact: YAN Xue-hua ,Email: 137552748@qq.com

摘要: 目的 探讨更新的中国重型乙型肝炎研究小组评分(Chinese Group on the Study of Severe Hepatitis B, COSSH)短期动态变化对乙型肝炎相关慢加急性肝衰竭(hepatitis B virus-related acute-on-chronic liver failure, HBV-ACLF)患者的临床意义。方法 采用回顾性队列研究方法,选取兰州市第二人民医院2017年1月至2021年7月收治的99例HBV-ACLF患者,记录其一般特征、48小时和3~7天实验室检查指标,以及28天和90天预后,并分别计算入院时、48小时、3~7天的COSSH-ACLFⅡs评分。采用受试者工作特征(ROC)曲线和曲线下面积(AUC)评价各评分模型对患者短期预后的预测价值;采用分类变量分析HBV-ACLF患者COSSH-ACLFⅡs短期动态变化的临床预测价值。结果 COSSH-ACLFⅡs预测患者28天和90天病死率,最大AUC的敏感性和特异性最高,分别为75%/84%和86.8%/80.9%。35.86%的患者病情缓解或改善,42.4%病程稳定或波动,21.7%病情恶化。改善组患者生存率为87.8%,恶化组患者病死率为85.0%。结论 与终末期肝病模型(model for end-stage liver disease,MELD)评分、MELD-血清钠(MELD-Na)评分、器官功能衰竭评分(CLIF consortium organ failure score,CLIF-COFs)、CLIF-CACLF评分(CLIF-consortium ACLF score,CLIF-C ACLFs)相比,COSSH-ACLFⅡs对HBV-ACLF具有更高的敏感性和特异性。COSSH-ACLFⅡs可准确预测3~7天生存率。

关键词: 慢加急性肝衰竭, 预测模型, 动态变化, 回顾性队列研究

Abstract: Objective To investigate the clinical significance of the short-term dynamic changes of the new COSSH score (COSSH-ACLFⅡs) in patients with hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF). Methods This is a retrospective cohort study with 99 HBV-ACLF patients who were admitted in Lanzhou Second People's Hospital., The general characteristics, 48hr, 3~7 d laboratory examination index, 28 d and 90 d prognosis were recorded, and the prognosis score at admission, 48 hr and 3~7 d COSSH-ACLFⅡs score were calculated, respectively. The receiver operating characteristic (ROC) curve and the area under the curve (AUC) were used to evaluate the predictive value of each scoring model on the short-term prognosis of the studied patients. The clinical predictive value of the short-term dynamic changes of COSSH-ACLFⅡs in HBV-ACLF was analyzed by classified variables. Results The largest AUC of COSSH-ACLFIIs to predict the 28d and 90d deaths of patients had the highest sensitivity and specificity (75% vs. 84% and 86.8% vs. 80.9%, respectively). The COSSH-ACLFIIs resolved or improved in 35.86% of patients, had a steady or fluctuating course in 42.4% and worsened in 21.7% of patients. In the improvement group, 87.8% of patients survived, while in the deterioration group, 85.0% of patients died. Conclusion In comparison with MELD, MELD-Na, CLIF-COFs, and CLIF-CACLFs, COSSH-ACLFIIs has higher sensitivity and specificity for predicting HBV-ACLF. The Survival of 3~7d can be accurately predicted after evaluation with COSSH-ACLFIIs.

Key words: Acute-on-chronic liver failure, Prediction model, Dynamic change, Retrospective cohort study